We are live on ! Find out more
UAG

ETRACS UBS Bloomberg CMCI Agriculture ETN

Delisted

UAG was delisted on the 9th of December, 2020.

1 hedge funds and large institutions have $1K invested in ETRACS UBS Bloomberg CMCI Agriculture ETN in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

75% less capital invested

Capital invested by funds: $4K → $1K (-$3K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$2.75K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
1
Tower Research Capital (TRC)
New York
$1K -$2.75K -132 -66%

UAG Hedge Fund Activity: Q2 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ETRACS UBS Bloomberg CMCI Agriculture ETN (UAG) for Q2 2016, worth a combined $1K — down 75% from $4K a quarter earlier.

Fund positioning in UAG was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Tower Research Capital (TRC), cutting an estimated $2.75K.

  • 1 institutional investor held ETRACS UBS Bloomberg CMCI Agriculture ETN (UAG) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $1K of ETRACS UBS Bloomberg CMCI Agriculture ETN stock for Q2 2016, down 75% quarter-over-quarter.
  • 0 funds opened new ETRACS UBS Bloomberg CMCI Agriculture ETN positions in Q2 2016 and 0 closed out.
  • The largest ETRACS UBS Bloomberg CMCI Agriculture ETN seller in Q2 2016 was Tower Research Capital (TRC), an estimated $2.75K sold.

Based on aggregated 13F filings for Q2 2016.